Glivec

Made by

• Novartis

Active Ingredient

Imatinib mesylate

Prospectus

Approval date

2001/11/21

Treats

• B-cell acute lymphoblastic leukemia, B-cell acute lymphocytic leukemia
• Hypereosinophilic syndrome
• Chronic eosinophilic leukemia
• Chronic myeloid leukemia
• Gastrotintestinal stromal tumor

Dosages

• Glivec Tablets 100mg - 2090.5円／錠